Koninklijke Philips N.V. PHG
At closeNov 4, 2026, 4:03 PM EST
After hours · Nov 4, 4:03 PM ET
- YTD
- +14.70%
- 1 year
- +10.85%
- Market cap
- 30.36B
- Revenue (ttm)
- 17.76B
- Profit margin
- 5.39%
- EPS (ttm)
- 0.52
- Shares out
- 977.61M
- P/E ratio
- 59.73
- Forward P/E
- 16.45
- Dividend
- 1.01 (3.56%)
- Ex-dividend date
- May 12, 2026
- YTD return
- +14.70%
- 1-year return
- +10.85%
- Volume
- 3.02M
- Avg volume
- 1.00M
- Open
- 29.84
- Previous close
- 28.46
- Day's range
- 29.84 – 31.12
- 52-week range
- 23.62 – 33.44
- Analysts
- Hold
- Price target
- 32.02 (+3.1%)
- Earnings date
- Feb 9, 2027
2Y +3.95 (+14.59%)
Key statistics
- Enterprise value
- 33.24B
- PEG ratio
- 0.88
- Price / sales
- 1.71
- Price / book
- 2.40
- Dividend yield
- 3.56%
- Payout ratio
- 211.79%
- Revenue growth
- 2.10%
- Free cash flow
- 1.84B
- Total cash
- 2.75B
- Total debt
- 8.14B
- Return on equity
- 8.61%
- Short % of float
- 0.00%
- 50-day average
- 25.54
- 200-day average
- 27.19
Analyst view
Consensus: hold
- Target (low)
- 26.20
- Target (mean)
- 32.02
- Target (high)
- 41.00
- Strong buy2
- Buy0
- Hold3
- Sell0
- Strong sell0
Next earnings
Feb 9, 2027
Expected Feb 9, 2027. Consensus EPS estimate 0.61081.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 9, 2027 | Dec 30, 2026 | 0.69 | — | — | — |
| Nov 3, 2026 | Sep 30, 2026 | 0.37 | 0.46 | +0.09 | +24.32% |
| Jul 27, 2026 | Jun 30, 2026 | 0.40 | 0.57 | +0.17 | +42.50% |
| May 6, 2026 | Mar 31, 2026 | 0.24 | 0.27 | +0.03 | +12.50% |
| Feb 10, 2026 | Dec 31, 2025 | 0.565 | 0.70 | +0.14 | +23.89% |
| Nov 4, 2025 | Sep 30, 2025 | 0.37 | 0.37 | 0.00 | 0.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 3, 2026 | UBS | down | Buy | Neutral |
| Feb 20, 2025 | UBS | up | Neutral | Buy |
| Oct 29, 2024 | Jefferies | up | Underperform | Hold |
| May 13, 2024 | Bernstein | up | Market Perform | Outperform |
| Apr 30, 2024 | UBS | up | Sell | Neutral |
| Apr 30, 2024 | JP Morgan | up | Underweight | Neutral |
About Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Netherlands
- Website
- philips.com
News
Philips Launches HyperVue Integrated System to Improve PCI Workflows 
Philips Reports Strong Customer Demand, Improved Profitability 
Philips Reports Strong Customer Demand, Improved Profitability 
What Koninklijke Philips (PHG) Said on Its Q3 Earnings Call 
Koninklijke Philips N.V. (PHG) Q3 2026 Earnings Call Transcript 
Koninklijke Philips Q3 2026 Earnings Call Transcript 
Philips: The Recovery Is Real, But I Was Too Optimistic (Rating Downgrade) 
Koninklijke Philips (NYSE:PHG) Share Price Breaks Above 200 Day Moving Average – Here’s What Happened 
Philips Sales Rise Amid Product Recall Agreement 
Philips Reiterates FY2026 Outlook: Comparable Sales Growth 3%-4.5%, Adjusted EBITA Margin 13.5%-14.0%, Free Cash Flow EUR 1.5B-1.7B, Including US Tariff Refund Benefits
Your note
Sign in to keep a note on PHG — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Exor N.V. | 18.92% | 185,932,684 | 5.77B | Jun 29, 2026 |
| Mondrian Investment Partners Ltd | 0.80% | 7,885,781 | 244.77M | Sep 29, 2026 |
| Dimensional Fund Advisors LP | 0.44% | 4,340,691 | 134.74M | Jun 29, 2026 |
| Fiduciary Management, Inc. | 0.35% | 3,459,961 | 107.40M | Jun 29, 2026 |
| Causeway Capital Management LLC | 0.31% | 3,061,962 | 95.04M | Jun 29, 2026 |
| Morgan Stanley | 0.30% | 2,935,662 | 91.12M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMI Funds Inc-Large Cap Fund | 0.12% | 1,215,000 | 37.71M | Jun 29, 2026 |
| Dimensional ETF Trust-Dimensional International Value ETF | 0.10% | 995,485 | 30.90M | Jul 30, 2026 |
| DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT. | 0.10% | 1,017,635 | 31.59M | Jul 30, 2026 |
| DFA INVESTMENT TRUST CO-The DFA International Value Series | 0.06% | 630,121 | 19.56M | Jul 30, 2026 |
| Liberty All Star Equity Fund | 0.05% | 454,135 | 14.10M | Jun 29, 2026 |
| Dimensional ETF Trust-Dimensional International Core Equity 2 ETF | 0.04% | 388,912 | 12.07M | Jul 30, 2026 |